-- 
Agilent, DaVita, JDS Uniphase, New York Times, Union: U.S. Equity Movers

-- B y   I n y o u n g   H w a n g
-- 
2011-03-04T21:26:56Z

-- http://www.bloomberg.com/news/2011-03-03/cooper-kodiak-marvell-technology-novell-wal-mart-u-s-equity-preview.html
Shares of the following companies
had unusual moves in U.S. trading. Stock symbols are in
parentheses, and prices are as of 4 p.m. in  New York .    Agilent Technologies Inc. (A)   rose 9.2 percent, the most
in the  Standard & Poor’s 500  Index, to $46.75. The world’s
biggest maker of scientific-testing equipment increased its
long-term sales and operating margin forecasts at a meeting with
analysts yesterday, JPMorgan Chase & Co. said in a note to
clients.    JDS Uniphase Corp. (JDSU)  , which bought Agilent’s
network solutions test unit last year, climbed 8.9 percent to
$27.37, the second-biggest gain in the Standard & Poor’s 500.    Cadence Pharmaceuticals Inc. (CADX)   rallied 15 percent,
the most since March 2009, to $8.62. The San Diego-based
biopharmaceutical company reported a loss of 33 cents a share in
the fourth quarter, 1 cent narrower than the average analyst
estimate in a Bloomberg survey.    Central European Distribution Corp. (CEDC)   fell 8.3
percent to $12.79 for the second-biggest retreat in the Russell
1000 Index. Credit Suisse Group AG downgraded the vodka maker to
“underperform” from “outperform,” while Moody’s Investors
Service said it may lower the company’s debt rating.    Cerus Corp. (CERS)   dropped 14 percent, the most since
Nov. 10, to $2.90. The company, which develops systems designed
to enhance the safety of blood transfusions, reported fourth-
quarter revenue of $6.46 million, trailing the average analyst
estimate by 15 percent, Bloomberg data show. Robert W. Baird &
Co. cut the stock to “neutral” from “outperform.”  Cooper Cos. (COO US) advanced 10 percent to $70.10 for the
biggest increase in the Russell 1000 Index. The maker of  contact
lenses  and medical devices posted quarterly earnings excluding
some items that exceeded the average analyst estimate by 26
percent, Bloomberg data show.    DaVita Inc. (DVA)   gained 3.7 percent to $83.76, the
highest price since at least October 1995. Health-care advisory
firm Marwood Group said the Centers for Medicare & Medicaid
Services is in the final stage of revising “transition
adjustment to budget neutrality” as end-stage renal disease
payments move to bundled system.    Kodiak Oil & Gas Corp. (KOG)   declined 4.6 percent to
$6.98, the lowest price since Feb. 23. The oil and natural gas
explorer in the western U.S. posted revenue that fell short of
analyst forecasts.    LSB Industries Inc. (LXU)   rose 13 percent to $36.28, the
highest price since at least 1980. The maker of chemical and
climate control products reported fourth-quarter profit of 79
cents a share, more than double the average analyst estimate in
a Bloomberg survey.    Madison Square Garden Inc. (MSG)   slipped 5.4 percent,
the most since July 8, to $28.10. The owner of the  New York
Knicks  reported fourth-quarter profit that missed analysts’
estimates. Miller Tabak Co. cut the stock’s rating to
“neutral” from “buy.”    Marvell Technology Group Ltd. (MRVL)   had the biggest
loss in the Russell 1000 Index, sliding 12 percent to $16.13.
The maker of the processor that runs BlackBerry smartphones
announced fourth-quarter adjusted earnings and revenue that
missed estimates.    Monster Worldwide Inc. (MWW)   slipped 6.4 percent to
$15.90 for the biggest decline in the  S&P 500 Index . The online-
recruiting company was cut to “market perform” from
“outperform” at William Blair & Co.    New York Times Co. (NYT)   sank 5.7 percent, the most
since Sept. 22, to $10.24. Lazard Capital Markets Ltd. analyst
William Bird initiated coverage of the newspaper owner with a
“sell” rating, citing increasing pressure in print as
advertising shifts online.  Rival Gannett Co. (GCI US) slipped 2.6 percent to $16.24.    Spreadtrum Communications Inc. (SPRD)   rose 6.7 percent,
the most since Nov. 2, to $23.07. The Chinese maker of mobile-
phone chips reported fourth-quarter sales of $126.5 million,
beating the average analyst estimate of $123.4 million in a
Bloomberg survey.    Union Drilling Inc. (UDRL)   climbed 28 percent, the most
since October 2008, to $9.70. The contract-drilling service
provider reported fourth-quarter adjusted loss was 4 cents,
beating the 11-cent loss average estimate by analysts.  Gabelli & Co. raised its recommendation on the Fort Worth,
Texas-based company to a “buy” from “hold.”    USA Mobility Inc. (USMO)   slipped 6 percent to $13.43,
the lowest price since Aug. 13. The provider of wireless
messaging services said it acquired Amcom Software Inc. for
$163.3 million.    Vivus Inc. (VVUS)   fell 9.4 percent to $6.39, the lowest
price since Nov. 26. U.S. regulators said there was a risk of  birth defects  from the drug topiramate, one ingredient in the
company’s experimental weight-loss drug Qnexa.  To contact the reporter on this story:
Inyoung Hwang in New York at 
 ihwang7@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at 
 nbaker7@bloomberg.net  